Some interesting suggestions William. I do agree with other posters who suggest that we are going to need a capital raise in the not too distant future if we don't do some sort of a deal but the company certainly seems to be focused on taking this to the clinic before any deals are done. I am basing that opinion on the response I got in relation to my inquiry on the manufacturing capabilities of the company -
"The Clinical roadmap ahead is both exciting and significant, meaning a considerable expansion and scale-up of current capacity is likely, as opposed to a contraction."
I wonder if company could ever scale up production to the extent that it becomes a supplier of heart valves to the market?
PCR London, page-40
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.50 |
Change
0.000(0.00%) |
Mkt cap ! $243.1M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $11.50 | $11.00 | $344.4K | 30.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $11.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 4417 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |